Form 8-K - Current report:
SEC Accession No. 0001140361-24-043915
Filing Date
2024-10-22
Accepted
2024-10-22 17:09:12
Documents
48
Period of Report
2024-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20037500_8k.htm   iXBRL 8-K 99238
2 EXHIBIT 2.1 ef20037500_ex2-1.htm EX-2.1 1023108
3 EXHIBIT 3.1 ef20037500_ex3-1.htm EX-3.1 72389
4 EXHIBIT 3.2 ef20037500_ex3-2.htm EX-3.2 9369
5 EXHIBIT 3.3 ef20037500_ex3-3.htm EX-3.3 226127
6 EXHIBIT 99.1 ef20037500_ex99-1.htm EX-99.1 43699
7 EXHIBIT 99.2 ef20037500_ex99-2.htm EX-99.2 58622
11 image00001.jpg GRAPHIC 86995
12 image00002.jpg GRAPHIC 4812
13 image00003.jpg GRAPHIC 3802
14 image00004.jpg GRAPHIC 274574
15 image00005.jpg GRAPHIC 65367
16 image00006.jpg GRAPHIC 108177
17 image00007.jpg GRAPHIC 73804
18 image00008.jpg GRAPHIC 109667
19 image00009.jpg GRAPHIC 155446
20 image00010.jpg GRAPHIC 93974
21 image00011.jpg GRAPHIC 140740
22 image00012.jpg GRAPHIC 49174
23 image00013.jpg GRAPHIC 154754
24 image00014.jpg GRAPHIC 105953
25 image00015.jpg GRAPHIC 100663
26 image00016.jpg GRAPHIC 122496
27 image00017.jpg GRAPHIC 113592
28 image00018.jpg GRAPHIC 115305
29 image00019.jpg GRAPHIC 45221
30 image00020.jpg GRAPHIC 128475
31 image00021.jpg GRAPHIC 119092
32 image00022.jpg GRAPHIC 91585
33 image00023.jpg GRAPHIC 147170
34 image00024.jpg GRAPHIC 71352
35 image00025.jpg GRAPHIC 135021
36 image00026.jpg GRAPHIC 130757
37 image00027.jpg GRAPHIC 98350
38 image00028.jpg GRAPHIC 117332
39 image00029.jpg GRAPHIC 129332
  Complete submission text file 0001140361-24-043915.txt   6255652

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ocup-20241022.xsd EX-101.SCH 3982
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20241022_lab.xml EX-101.LAB 22691
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20241022_pre.xml EX-101.PRE 16552
50 EXTRACTED XBRL INSTANCE DOCUMENT ef20037500_8k_htm.xml XML 4245
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 241387005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)